Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

MARCKSL1 is important for wound healing and could be a target to reduce scarring.

The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

A new gene mutation causes insulin resistance in a girl and her mother.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

HR protein causes abnormal hair cycles by increasing Tgf-β2 and reducing miR-31.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Dual TCR Treg cells are common in mouse tissues and vary by location.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Lef1 is essential for normal skin, hair growth, and healing wounds in mice.

The CRH/CRH-R1 system might be involved in causing lichen planus.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Blocking IL-17a can improve age-related smell loss in mice.

Rheumatologists are crucial in managing interstitial lung disease by working closely with respiratory specialists.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.